A randomized placebo-controlled trial of infliximab therapy for active ulcerative colitis: Act I trial

被引：0
|
作者：
Rutgeerts, P
Feagan, BG
Olson, A
Johanns, J
Travers, S
Present, D
Sands, BE
Sandborn, W
Olson, A
机构：
来源：
GASTROENTEROLOGY | 2005年 / 128卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：A35 / A36
页数：2
相关论文
共 50 条
  • [1] A randomized placebo-controlled trial of infliximab therapy for active ulcerative colitis: ACT 1 trial results through week 54
    Sandborn, WJ
    Feagan, BG
    Olson, A
    Johanns, J
    Travers, S
    Present, D
    Sands, BE
    Rutgeerts, P
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2005, 100 (09): : S313 - S313
  • [2] Rosiglitazone for active ulcerative colitis: A randomized placebo-controlled trial
    Lewis, James D.
    Lichtenstein, Gary R.
    Deren, Julius J.
    Sands, Bruce E.
    Hanauer, Stephen B.
    Katz, Jeffrey A.
    Lashner, Bret
    Present, Daniel H.
    Chuai, Shaokun
    Ellenbergr, Jonas H.
    Nessel, Lisa
    Wu, Gary D.
    GASTROENTEROLOGY, 2008, 134 (03) : 688 - 695
  • [3] A randomized, placebo-controlled trial of the PPARγ ligand rosiglitazone for active ulcerative colitis
    Lewis, J. D.
    Lichtenstein, G. R.
    Deren, J. J.
    Chuai, S.
    Ellenberg, J. H.
    Nessel, L.
    Wu, G. D.
    Sands, B. E.
    Hanauer, S. B.
    Katz, J. A.
    Lashne, B.
    Present, D. H.
    GASTROENTEROLOGY, 2007, 132 (07) : 2585 - 2585
  • [4] A Randomized placebo-controlled trial of pegylated interferon alpha in active ulcerative colitis
    Tilg, H
    Vogelsang, H
    Ludwiczek, O
    Lochs, H
    Colombel, JF
    Rutgeerts, L
    Ulmer, H
    Kruger, S
    Cortot, A
    D'Haens, G
    Kaser, A
    Harrer, M
    Kuhn, I
    Reimsch, W
    GASTROENTEROLOGY, 2003, 124 (04) : A62 - A62
  • [5] Mercaptopurine for the Treatment of Ulcerative Colitis: A Randomized Placebo-Controlled Trial
    Lowenberg, Mark
    Volkers, Adriaan
    van Gennep, Sara
    Mookhoek, Aart
    Montazeri, Nahid
    Clasquin, Esme
    Duijvestein, Marjolijn
    van Bodegraven, Adriaan
    Rietdijk, Svend
    Jansen, Jeroen
    van Asseldonk, Dirk
    van der Zanden, Esmerij
    Dijkgraaf, Marcel
    West, Rachel
    de Boer, Nanne
    D'Haens, Geert
    JOURNAL OF CROHNS & COLITIS, 2023, 17 (07): : 1055 - 1065
  • [6] Randomized, placebo-controlled trial of low molecular weight heparin in active ulcerative colitis
    de Bievre, M. A.
    Vrij, A. A.
    Schoon, E. J.
    Dijkstra, G.
    de Jong, A. E.
    Woolthuis, A. H. Oberndorff-Klein
    Hemker, H. C.
    Stockbrugger, R. W.
    INFLAMMATORY BOWEL DISEASES, 2007, 13 (06) : 753 - 758
  • [7] A randomized, placebo-controlled trial of low molecular weight heparin in active ulcerative colitis
    De Bievre, MA
    Vrij, AA
    Woolthuis, AHOK
    Hemker, HC
    Stockbrugger, RH
    GASTROENTEROLOGY, 2003, 124 (04) : A68 - A68
  • [8] A randomized, placebo controlled trial of fecal microbiota therapy in active ulcerative colitis.
    Moayyedi, Paul
    Surette, Michael
    Wolfe, Melanie
    Taraschi, Rita
    Kim, Peter
    Libertucci, Josie
    Armstrong, David
    Marshall, John K.
    Reinisch, Walter
    Lee, Christine H.
    GASTROENTEROLOGY, 2014, 146 (05) : S159 - S159
  • [9] AMISELIMOD FOR THE TREATMENT OF ACTIVE ULCERATIVE COLITIS: A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL
    Hanauer, Stephen B.
    Laitman, Adam P.
    Heimanson, Zeev
    Israel, Robert J.
    Lee, Jimin
    Schreiber, Stefan
    GASTROENTEROLOGY, 2024, 166 (05)
  • [10] A randomized, double blinded, placebo-controlled clinical trial of silymarin in ulcerative colitis
    Mansoor Rastegarpanah
    Reza Malekzadeh
    Homayoun Vahedi
    Maryam Mohammadi
    Elham Elahi
    Meghedi Chaharmahali
    Tahereh Safarnavadeh
    Mohammad Abdollahi
    Chinese Journal of Integrative Medicine, 2015, 21 : 902 - 906
12345